Methods

CP-WOPT algorithm for data completion
We compare the performance of TT-WOPT algorithm with that of CANDECOMP/PARAFAC weighted optimization (CP-WOPT) that analyzes a real-valued tensor, X ∈ R I 1 ×I 2 ×...×I N , with missing entries [1] . The index of the missing entries can be recorded by a weight tensor (W), the size of which is same as that of X. Each entry of W satisfies the following conditions:
..i N is a missing entry, 1 if x i 1 i 2 ...i N is an observed entry.
CP decomposition decomposes a tensor into a sequence of matrices. The CP decomposition of the tensor X ∈ R I 1 ×I 2 ×...×I N can be expressed as follows:
where A (1) , A (2) , ..., A (N) is a sequence of matrices of size I 1 × R, I 2 × R, ..., I N × R, respectively. The R is referred to as CP-ranks, which can limit the size of each matrix. Each element of tensor X can be written in the following index form:
where a (n) i n r is the the (i n , r)-th element of the n-th matrix. In the optimization algorithm, the objective variables are the elements of all matrices. Here, the objective function can be written as follows:
where Y = W * X and Z = W * ⟨⟨ A (1) , A (2) , ..., A (N) ⟩⟩ ( * is the Hadamard product; [2] ). For n = 1, ..., N, the partial derivatives of the objective function with respect to the n-th matrixA (n) can be expressed as follows:
where
The symbol ⊙ denotes the Khatri-Rao product [3] . After the objective function and the derivation of gradient are obtained, we can solve the optimization problem by any optimization algorithms based on gradient descent method [4] . In this study, the maximum iteration number was set to 300 as the stop criteria for optimization.
Multitask learning method for drug indication prediction
We address the problem of therapeutic indications prediction by focusing on drugs. Note that there are a number of candidates for diseases, and different diseases may have common characteristics in terms of molecular mechanisms. The same drugs are sometimes used for multiple diseases. Thus, we propose formulating the problem in the framework of supervised multiple label prediction.
Suppose that there are M diseases and we are given P drugs. We consider predicting which diseases would be treated by a drug, that is, the i-th drug. Each drug is represented by a d-dimensional feature vector as x i in this study, where x i was obtained by averaging the multiple signatures from different cell lines.
We constructed a learning set of drug-disease pairs that are pairs given in drugdisease associations (see the Materials section for more details). There are M candidates for diseases, and each drug in the learning set is assigned a binary class label representing the m-th disease (m = 1, 2, ..., M). Let y m,i ∈ {0, 1} be the class label for the m-th disease assigned to the i-th drug, where y m,i = 1 means that the i-th drug is used for the m-th disease, and y m,i = 0 means that the i-th drug is not used for the m-th disease.
We construct a predictive model to predict whether the i-th drug would be used for the m-th disease (m = 1, 2, ..., M). Linear models are a useful tool to analyze extremely high-dimensional data for both prediction and feature extraction tasks. Thus, we adopt a linear function defined as f m = w To overcome the scarcity of existing knowledge concerning relationships between drugs and diseases, we propose learning individual predictive models f 1 , f 2 , ..., f M jointly, sharing information across M diseases.
We attempt to estimate all of the weight vectors w 1 , w 2 , ..., w M jointly in the models by minimizing the logistic loss as follows:
We introduce a regularization term Ω(W) to the loss function in order to enhance the generalization properties. Thus, the optimization problem is written as follows:
Here we introduce two regularization terms. First, we use a standard ridge regularization term to avoid the over-fitting problem, which is defined as
Second, we design another regularization term reflecting the similarities among diseases. In this study we evaluate the similarity among diseases using the Jaccard coefficient and construct an M × M similarity matrix S for diseases in which each element S i, j is a similarity score between the i-th and j-th diseases (see section 2.2 for more details). Then, we introduce the following regularization term:
where ∥ · ∥ is the Euclidean norm, K is a diagonal matrix defined as
The regularization term Ω s (W) has the effect of bringing the weight vectors w i and w j close to each other if S l,m is high.
Finally, we introduce the following regularization term in the optimization problem (1):
where λ s ≥ 0 and λ r ≥ 0 are hyper-parameters to control the strength of the regularization terms Ω s and Ω r , respectively.
Results
A large-scale prediction of new therapeutic indications
We performed a comprehensive prediction of unknown therapeutic indications of 1,483 drugs. For these drugs, the gene expression data are available in the LINCS database. We used all known drug-disease associations as a learning dataset and predicted new drug therapeutic indications by the multitask learning method with tensor decomposition. Here, the possible therapeutic indications were related to 79 diseases. Supplementary Figure 3 shows the distribution of drugs repositioned from the original disease class to other disease classes based on the predicted therapeutic indications of drugs. Diseases are classified according to the 10th revision of the International Classification of Diseases (ICD-10; [5] ) disease chapters. The prediction resulted in the largest number of drugs that were possibly repositioned from chapter I of the ICD-10 (certain infectious and parasitic diseases) to chapter II of the ICD-10 (neoplasms) and vice versa, followed by possible drug repositioning from chapter II of the ICD-10 (neoplasms) to chapter IV of the ICD-10 (endocrine, nutritional, and metabolic diseases) and vice versa. These results suggest that the proposed approach for a largescale prediction can provide new therapeutic indications for a wide range of diseases.
Supplementary Figure 4 shows the network of drug-disease associations that are predicted by only the multitask learning method with the tensor decomposition. Here, the associations are shown by focusing on drugs repositioned from the original disease class to other disease classes based on the new therapeutic indications of drugs. For example, niclosamide (D00436), an anthelmintic drug, was predicted to have therapeutic efficacy in adult T-cell leukemia. Adult T-cell leukemia and lymphoma (ATL) is a highly aggressive form of hematological malignancy and is caused by chronic infection with the human T-cell leukemia virus type 1 (HTLV-1). Researchers reported that niclosamide induced apoptosis of HTLV-1-transformed T cells [6] . This implies that, via a large-scale analysis, finding the therapeutic indications of drugs approved for various diseases is possible.
Supplementary Table 1 . Performance evaluation of data completion by tensor decomposition algorithms for third-order transcriptome data (drugs, genes, and cell lines) with different rates of artificial missing values. Missing values were generated by the "random missing" strategy. Relative standard errors (RSEs) between the original and reconstructed data from tensor decomposition were calculated for (a) all values and (b) missing values only. The proposed TT-WOPT method and the baseline CP-WOPT method are denoted as TT and CP, respectively. The optimized tensor ranks are shown for each method. Artificially generated missing rates of 10%, 50%, and 90% were tested. Cell lines are listed in order of increasing original missing rates. Supplementary Table 2 . Performance evaluation of data completion by tensor decomposition algorithms for fourth-order transcriptome data (drugs, genes, cell lines, and time points) with artificial missing values. Missing values were generated by the "random missing" strategy. Relative standard errors (RSEs) between the original and reconstructed data from tensor decomposition were calculated for (a) all values and (b) missing values only. The proposed TT-WOPT method and the baseline CP-WOPT method are denoted as TT and CP, respectively. The optimized tensor ranks are shown for each method. Artificially generated missing rates of 10%, 50%, and 90% were tested. Cell lines are listed in order of increasing original missing rates. 
